DK1259248T3 - Fremgangsmåde til behandling af cancere, der udtrykker vaskulær endotelvækstfaktor D - Google Patents
Fremgangsmåde til behandling af cancere, der udtrykker vaskulær endotelvækstfaktor DInfo
- Publication number
- DK1259248T3 DK1259248T3 DK01913267T DK01913267T DK1259248T3 DK 1259248 T3 DK1259248 T3 DK 1259248T3 DK 01913267 T DK01913267 T DK 01913267T DK 01913267 T DK01913267 T DK 01913267T DK 1259248 T3 DK1259248 T3 DK 1259248T3
- Authority
- DK
- Denmark
- Prior art keywords
- growth factor
- vascular endothelial
- endothelial growth
- treating cancers
- cancers expressing
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18636100P | 2000-03-02 | 2000-03-02 | |
EP01913267A EP1259248B1 (fr) | 2000-03-02 | 2001-03-02 | Procedes de traitement de cancers exprimant le facteur d de croissance endotheliale vasculaire |
PCT/US2001/006791 WO2001064235A1 (fr) | 2000-03-02 | 2001-03-02 | Procedes de traitement, d'examen et de detection de cancers exprimant le facteur d de croissance endotheliale vasculaire |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1259248T3 true DK1259248T3 (da) | 2005-04-11 |
Family
ID=34195970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01913267T DK1259248T3 (da) | 2000-03-02 | 2001-03-02 | Fremgangsmåde til behandling af cancere, der udtrykker vaskulær endotelvækstfaktor D |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1519193B1 (fr) |
DK (1) | DK1259248T3 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7211240B2 (en) | 2002-03-01 | 2007-05-01 | Bracco International B.V. | Multivalent constructs for therapeutic and diagnostic applications |
EP1587944A4 (fr) | 2002-03-01 | 2007-03-21 | Dyax Corp | Peptides de liaison kdr et vegf/kdr et leur utilisation a des fins diagnostiques et therapeutiques |
US8623822B2 (en) | 2002-03-01 | 2014-01-07 | Bracco Suisse Sa | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
US7666979B2 (en) | 2002-03-01 | 2010-02-23 | Bracco International B.V. | Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same |
US7794693B2 (en) | 2002-03-01 | 2010-09-14 | Bracco International B.V. | Targeting vector-phospholipid conjugates |
US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
US7595149B1 (en) | 2004-11-08 | 2009-09-29 | University Of Kentucky Research Foundation | Methods for cancer detection |
DE102007037008B4 (de) * | 2007-08-06 | 2015-09-10 | Siemens Aktiengesellschaft | Diagnosesubstanz zur Anwendung in einem Verfahren zur Bestimmung der Aggressivität eines Prostatatumors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE294863T1 (de) * | 1996-07-15 | 2005-05-15 | Chugai Pharmaceutical Co Ltd | Neuartige vegf-ähnliche faktoren |
WO1998007832A1 (fr) * | 1996-08-23 | 1998-02-26 | Ludwig Institute For Cancer Research | Facteur d recombinant de croissance des cellules endotheliales vasculaires (vegf-d) |
DE69839529D1 (de) * | 1997-12-24 | 2008-07-03 | Ludwig Inst Cancer Res | Expressionsvektoren und zellinien zur expression von vaskulärem wachstumsfaktor d, sowie verfahren zur behandlung von melanomen |
-
2001
- 2001-03-02 EP EP04027975A patent/EP1519193B1/fr not_active Expired - Lifetime
- 2001-03-02 DK DK01913267T patent/DK1259248T3/da active
Also Published As
Publication number | Publication date |
---|---|
EP1519193B1 (fr) | 2011-11-09 |
EP1519193A2 (fr) | 2005-03-30 |
EP1519193A3 (fr) | 2007-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1132569T3 (da) | Fremgangsmåde til behandling af en underjordisk formation | |
DE60042611D1 (de) | Verfahren zur behandlung von gefässerkrankungen, dxid auszeichnen | |
DK2412368T3 (da) | Sammensætning til behandling af ar | |
AU2002333623A1 (en) | Antisense modulation of vascular endothelial growth factor receptor-1 expression | |
DK1161426T3 (da) | Fremgangsmåde til fremstilling af furfural | |
NL1014915A1 (nl) | Nieuwe behandelingsmethode. | |
DE50102118D1 (de) | Verfahren zur herstelling von 1,2-dichlorethan | |
ATE277920T1 (de) | Verfahren zur vorbereitung von reinem citalopram | |
NO20030364L (no) | Sikt og fremgangsmåte for fremstilling av sikt | |
DK1333853T3 (da) | Vækstfaktorkompleks | |
DE60114294D1 (de) | Vorrichtungen und Verfahren zur Verstärkung von geschlossenen, konstruktiven Bauelementen | |
DK1109571T3 (da) | Fremgangsmåde til behandling af saltafhængig hypertension | |
TR199800608A3 (tr) | Propanolamin türevleri, bunlarin üretim usulü. | |
DK1259248T3 (da) | Fremgangsmåde til behandling af cancere, der udtrykker vaskulær endotelvækstfaktor D | |
NO20030579L (no) | Vaskulaere grafter og fremgangsmater til implantering derav | |
AU2003216389A8 (en) | Induction of hair growth with vascular endothelial growth factor | |
DE60131397D1 (de) | Verfahren zur gewinnung von cetamin-enantiomeren. | |
FI20000194A0 (fi) | Menetelmä kaupankäynnissä | |
ATA21152000A (de) | Verfahren zur herstellung von wolframcarbid | |
IS6888A (is) | Aðferð við meðferð sykursýki af gerð I | |
DK1341758T3 (da) | Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme | |
NO20015162L (no) | Fremgangsmåte for behandling av nevrodegenerering | |
FI20002695A (fi) | Suodatusmenetelmä | |
DE60043956D1 (de) | Herstellungsverfahren von Lampen | |
NO20011056L (no) | Fremgangsmate for utvelging av stivelse |